Clinical Trials at Midland Clinical Research Center
During the past decade, Midland Clinical Research Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year
This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months
A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms
2018-12-04
2023-12-29
Active, not recruiting
128
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Midland Clinical Research Center" #1 sponsor was "Pfizer" with 2 trials, followed by "AstraZeneca" with 1 trials
sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Midland Clinical Research Center"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "The Cleveland Clinic" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Midland Clinical Research Center
According to Clinical.Site data, the most researched conditions in "Midland Clinical Research Center" are
"Cardiovascular Disease" (3 trials), "Arthritis, Rheumatoid" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "High Cardiovascular Risk" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Midland Clinical Research Center" in a lesser frequency.
Clinical Trials Intervention Types at Midland Clinical Research Center
Most popular intervention types in "Midland Clinical Research Center" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Dapagliflozin" (1 trials), "Ibuprofen" (1 trials) and "Lorcaserin hydrochloride" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Midland Clinical Research Center
The vast majority of trials in "Midland Clinical Research Center" are
6 trials for "All" genders.
Clinical Trials Status at Midland Clinical Research Center
Currently, there are NaN active trials in "Midland Clinical Research Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Midland Clinical Research Center,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Midland Clinical Research Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".